http://stroke.ahajournals.org/content/47/2/301.extract?etoc
A User’s Guide
- Joseph P. Broderick, MD;
- Yuko Y. Palesch, PhD;
- L. Scott Janis, PhD,
- for the National Institutes of Health StrokeNet Investigators
+ Author Affiliations
- Correspondence to Joseph P. Broderick, MD, Department of Neurology and Rehabilitation Medicine, University of Cincinnati Neuroscience Institute, 260 Stetson St, Suite 2300, PO Box 670525, Cincinnati, OH, 45267. E-mail joseph.broderick@uc.edu
See related article, p 304.
The National Institute of Neurological
Disorders and Stroke (NINDS) established the National Institutes of
Health (NIH) StrokeNet
to facilitate the rapid initiation and efficient
implementation of small and large multisite exploratory and
confirmatory
clinical trials focused on promising
interventions for stroke prevention, treatment, and recovery, as well as
validation studies
of biomarkers or outcome measures. The network
is open to execute high-effect trial ideas that can come from any corner
of
the wide stroke community. This network, which
was initiated in the Fall of 2013, currently involves 288 hospitals
across
the United States and is designed to serve as
the infrastructure and pipeline for new potential treatments for
patients with
stroke and those at risk of stroke. NIH
StrokeNet also provides a tremendous educational platform for stroke
physicians and
other healthcare professionals, particularly
those individuals in training and focused on an academic career. To
maximize
the effect of NIH StrokeNet, it is important for
the larger stroke community to know its structure and the process and
timeline
by which stroke trials are developed and
implemented. For more detailed information on the NIH StrokeNet, its
ongoing trials,
and educational webinars, one can visit the
website https://www.nihstrokenet.org/.
No comments:
Post a Comment